-
Astria Therapeutics NASDAQ:ATXS Astria Therapeutics’ dedicated and passionate team is devoted to bringing life-changing therapies to patients and families impacted by HAE and rare and niche allergic and immunological diseases.
Location: | Website: astriatx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
194.4M
Cash
344.3M
Avg Qtr Burn
-23.52M
Short % of Float
10.50%
Insider Ownership
0.47%
Institutional Own.
-
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
navenibart (STAR-0215) Details Hereditary angioedema | Phase 3 Initiation | |
STAR-0215 Details Hereditary angioedema | Phase 2 Data readout | |
STAR-0310 Details Atopic dermatitis | Phase 1a Initiation |